Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
A process for the crosslinking of at least one polymer selected from polysaccharides and derivatives thereof, which is carried out in an aqueous solvent by the action of an effective and non-excessive amount of at least one crosslinking agent, characterized in that it is carried out on a mixture containing at least one low-molecular weight polymer and at least one high-molecular weight polymer. A process for the preparation of an injectable monophase hydrogel of at least one crosslinked polymer selected from polysaccharides and derivatives thereof. Crosslinked polymers and injectable monophase hydrogels respectively obtainable by each of said processes.
1. An injectable polymeric composition prepared by a process comprising the steps of:
providing a first hyaluronic acid salt having an intrinsic viscosity of 600 ml/g, and providing a second hyaluronic acid salt having an intrinsic viscosity of 2800 ml/g;
mixing the first hyaluronic acid salt and second hyaluronic acid salt at a weight ratio of 90:10, respectively;
cross-linking the mixture in an aqueous solvent in the presence of an effective and non-excessive amount of at least one cross-linking agent; and
homogenizing the crosslinked mixture to obtain the injectable composition.
2. The composition of claim 1 having a concentration of hyaluronic acid of between 10 and 40 mg/g.
3. The composition of claim 1 having a concentration of hyaluronic acid of between 20 and 30 mg/g.
4. The composition of claim 1 having a concentration of hyaluronic acid of 26 mg/g.
5. The composition of claim 1 having an injection force of 14 N through a 27 G ½ needle/100 N dynamometer.
6. The composition of claim 1 , wherein the cross-linking agent is 1,4-butanediol diglycidyl ether (BDDE).
7. An injectable polymeric composition prepared by a process comprising the steps of:
providing a first hyaluronic acid salt having an intrinsic viscosity of 600 ml/g, and providing a second hyaluronic acid salt having an intrinsic viscosity of 2800 ml/g;
mixing the first hyaluronic acid salt and second hyaluronic acid salt at a weight ratio of 77:23, respectively;
cross-linking the mixture in an aqueous solvent in the presence of an effective and non-excessive amount of at least one cross-linking agent; and
homogenizing the crosslinked mixture to obtain the injectable composition.
8. The composition of claim 7 having a concentration of hyaluronic acid of between 10 and 40 mg/g.
9. The composition of claim 7 having a concentration of hyaluronic acid of between 20 and 30 mg/g.
10. The composition of claim 7 having a concentration of hyaluronic acid of 26 mg/g.
11. The composition of claim 7 having an injection force of 15 N through a 27 G ½ needle/100 N dynamometer.
12. The composition of claim 7 , wherein the cross-linking agent is 1,4-butanediol diglycidyl ether (BDDE).